Bouzegaou Hassiba*, Zenai El-Hadj Mehdi, Zaoui Mustapha, Benhlima Mohamed and Sassi Souad
Specialist Doctor in Gastroenterology and Digestive Endoscopy, Oran Wilaya, Oran
*Corresponding Author: Bouzegaou Hassiba, Specialist Doctor in Gastroenterology and Digestive Endoscopy, Oran Wilaya, Oran Province, Algeria.
Received: April 09, 2020; Published: May 02, 2020
HCV is highly prevalent among patients on long term hemodialysis and is associated with poor prognosis; recently the emergence of combination of DAA has shown strong safety, efficacy and tolerability in treatment of HCV infection in hemodialysis patients.
Citation: Bouzegaou Hassiba., et al. “100% Sustained Viral Response with Combination of Direct Acting Antiviral Therapy in Patient on Long Term Hemodialysis”. Acta Scientific Gastrointestinal Disorders 3.6 (2020): 01.
Copyright: © 2020 Bouzegaou Hassiba., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.